Research output per year
Research output per year
Search results
-
2016
Pharmacokinetic profile of Optivate® (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease
Shaikh-Zaidi, R., Lubetsky, A., Inbal, A. & Dash, C., 1 Jan 2016, In: Haemophilia. 22, 1, p. e64-e67Research output: Contribution to journal › Letter › peer-review
Open Access -
1995
Very low frequency of "normandy type" mutations among type 1 von Willebrand disease families.
Inbal, A., Kornbrot, N., Mannucci, P. M. & Sadler, J. E., Feb 1995, In: Thrombosis and Haemostasis. 73, 2, p. 324 1 p.Research output: Contribution to journal › Letter › peer-review
3 Scopus citations -
1994
How to calculate the maximum risk [3]
Araujo, F., Araujo, A. R., Inbal, A., Epstein, O., Blickstein, D., Kornbrot, N., Brenner, B. & Martinowitz, U., 1994, In: Blood Coagulation and Fibrinolysis. 5, 5, p. 849-851 3 p.Research output: Contribution to journal › Letter › peer-review
-
1991
Warfarin antagonism by avocado
Blickstein, D., Shaklai, M. & Inbal, A., 13 Apr 1991, In: The Lancet. 337, 8746, p. 914-915 2 p.Research output: Contribution to journal › Letter › peer-review
31 Scopus citations